Thanks to proactive R&D work and robust product registration, Actavis achieved more than 720 product- and market launches in 2009, compared to over 660 in 2008, which was also a record year for the Group.

Actavis offers one of the broadest product portfolios and strongest pipelines in the generics industry with around 830 products on the market and about 350 products under development and pending registration. Actavis products are registered in more than 60 countries